Table of Content



1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations

2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview

3. Market Dynamics
3.1. Parent Market Analysis - Healthcare
3.2. Market Scope
3.3. Key Drivers
3.3.1. Outsourcing Of Clinical Trials
3.3.2. Growing Number Of Clinical Trials
3.3.3. Awareness Regarding The Benefits Of Using Ctm Software
3.3.4. Incidences Of Chronic Diseases
3.3.5. Research & Development
3.4. Key Restraints
3.4.1. Scarcity Of Skilled Healthcare Professionals
3.4.2. Cost Of Implementation
3.4.3. Security Concerns

4. Key Analytics
4.1. Impact Of Covid-19 On Clinical Trial Management Market
4.2. Key Market Trends
4.3. Porter’S Five Forces Analysis
4.3.1. Buyers Power
4.3.2. Suppliers Power
4.3.3. Substitution
4.3.4. New Entrants
4.3.5. Industry Rivalry
4.4. Opportunity Matrix
4.5. Vendor Landscape

5. Market By End-User
5.1. Pharmaceutical And Biopharmaceutical Companies
5.2. Clinical Research Organizations
5.3. Healthcare Providers

6. Market By Product Type
6.1. Enterprise-Based Ctm
6.2. Site-Based Ctm

7. Market By Deployment Model
7.1. Web-Based Deployment
7.2. On-Premise Deployment
7.3. Cloud-Based Deployment

8. Market By Component
8.1. Software
8.2. Hardware
8.3. Services

9. Geographical Analysis
9.1. Europe
9.1.1. Market Size & Estimates
9.1.2. Key Growth Enablers
9.1.3. Key Challenges
9.1.4. Key Players
9.1.5. Country Analysis
9.1.5.1. United Kingdom
9.1.5.2. Germany
9.1.5.3. France
9.1.5.4. Italy
9.1.5.5. Russia
9.1.5.6. Denmark
9.1.5.7. Hungary
9.1.5.8. Sweden
9.1.5.9. Spain
9.1.5.10. Rest Of Europe

10. Competitive Landscape
10.1. Key Strategic Developments
10.1.1. Mergers & Acquisitions
10.1.2. Product Launches & Developments
10.1.3. Partnerships, Contracts/Agreements & Collaborations
10.2. Company Profiles
10.2.1. Advarra (Forte Research Systems Inc)
10.2.2. Arisglobal Llc
10.2.3. Bioclinica Inc
10.2.4. Bio-Optronics Inc
10.2.5. Ibm Corporation
10.2.6. Medidata Solutions Inc
10.2.7. Mednet Solutions Inc
10.2.8. Oracle Corporation
10.2.9. Parexel International Corporation
10.2.10. Veeva Systems Inc



List of Figures

List Of Figures
Figure 1: Key Market Trends
Figure 2: Porter’S Five Forces Analysis
Figure 3: Opportunity Matrix
Figure 4: Vendor Landscape
Figure 5: Europe Clinical Trial Management Market, Growth Potential, By End-User, In 2021
Figure 6: Europe Clinical Trial Management Market, By Pharmaceutical And Biopharmaceutical Companies, 2022-2030 (In $ Million)
Figure 7: Europe Clinical Trial Management Market, By Clinical Research Organizations, 2022-2030 (In $ Million)
Figure 8: Europe Clinical Trial Management Market, By Healthcare Providers, 2022-2030 (In $ Million)
Figure 9: Europe Clinical Trial Management Market, Growth Potential, By Product Type, In 2021
Figure 10: Europe Clinical Trial Management Market, By Enterprise-Based Ctm, 2022-2030 (In $ Million)
Figure 11: Europe Clinical Trial Management Market, By Site-Based Ctm, 2022-2030 (In $ Million)
Figure 12: Europe Clinical Trial Management Market, Growth Potential, By Deployment Model, In 2021
Figure 13: Europe Clinical Trial Management Market, By Web-Based Deployment, 2022-2030 (In $ Million)
Figure 14: Europe Clinical Trial Management Market, By On-Premise Deployment, 2022-2030 (In $ Million)
Figure 15: Europe Clinical Trial Management Market, By Cloud-Based Deployment, 2022-2030 (In $ Million)
Figure 16: Europe Clinical Trial Management Market, Growth Potential, By Component, In 2021
Figure 17: Europe Clinical Trial Management Market, By Software, 2022-2030 (In $ Million)
Figure 18: Europe Clinical Trial Management Market, By Hardware, 2022-2030 (In $ Million)
Figure 19: Europe Clinical Trial Management Market, By Services, 2022-2030 (In $ Million)
Figure 20: Europe Clinical Trial Management Market, Country Outlook, 2021 & 2030 (In %)
Figure 21: United Kingdom Clinical Trial Management Market, 2022-2030 (In $ Million)
Figure 22: Germany Clinical Trial Management Market, 2022-2030 (In $ Million)
Figure 23: France Clinical Trial Management Market, 2022-2030 (In $ Million)
Figure 24: Italy Clinical Trial Management Market, 2022-2030 (In $ Million)
Figure 25: Russia Clinical Trial Management Market, 2022-2030 (In $ Million)
Figure 26: Denmark Clinical Trial Management Market, 2022-2030 (In $ Million)
Figure 27: Hungary Clinical Trial Management Market, 2022-2030 (In $ Million)
Figure 28: Sweden Clinical Trial Management Market, 2022-2030 (In $ Million)
Figure 29: Spain Clinical Trial Management Market, 2022-2030 (In $ Million)
Figure 30: Rest Of Europe Clinical Trial Management Market, 2022-2030 (In $ Million)

List of Tables

LIST OF TABLES
TABLE 1: MARKET SNAPSHOT - CLINICAL TRIAL MANAGEMENT
TABLE 2: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, BY END-USER, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 3: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, BY END-USER, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 4: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, BY PRODUCT TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 5: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, BY PRODUCT TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 6: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, BY DEPLOYMENT MODEL, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 7: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, BY DEPLOYMENT MODEL, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 8: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, BY COMPONENT, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 9: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, BY COMPONENT, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 10: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 11: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 12: KEY PLAYERS OPERATING IN EUROPE CLINICAL TRIAL MANAGEMENT MARKET
TABLE 13: LIST OF MERGERS & ACQUISITIONS
TABLE 14: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 15: LIST OF PARTNERSHIPS, CONTRACTS/AGREEMENTS & COLLABORATIONS